Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AstraZeneca plc buy Gilbert

Start price
€87.23
20.01.21 / 60%
Target price
-
20.01.22
Performance (%)
-1.82%
End price
€85.64
29.03.21
Summary
This prediction ended on 29.03.21 with a price of €85.64. With a performance of -1.82%, the BUY prediction by Gilbert finished with a loss. Dividends of €1.59 are taken into consideration when calculating the performance. Gilbert has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
AstraZeneca plc 3.236% 3.236% -0.513% 47.749%
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to Gilbert what are the pros and cons of AstraZeneca plc for the foreseeable future?

Pros
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Cons

Comments by Gilbert for this prediction

In the thread AstraZeneca plc diskutieren
Prediction Buy
Perf. (%) -1.82%
Target price 99.000
Change
Ends at 20.01.22

Buy mit Kursziel 99,0

Prediction Buy
Perf. (%) -1.82%
Target price
Change
Ends at 20.01.22

Kursziel geändert auf 0,0

Prediction Buy
Perf. (%) -1.82%
Target price 90.000
Change
Ends at 20.01.22

Kursziel gesetzt auf 90,0

Prediction Buy
Perf. (%) -1.82%
Target price 95.000
Change
Ends at 20.01.22

Kursziel geändert auf 95,0

Prediction Buy
Perf. (%) -1.82%
Target price
Change
Ends at 20.01.22

Kursziel geändert auf 0,0

In the thread Trading AstraZeneca plc
Prediction Buy
Perf. (%) -1.82%
Target price
Change
Ends at 20.01.22

Buy beendet